Disease Intelligence Live Experience™

See the intelligence move from question to action.

This is a synthetic, interactive demonstration of the product architecture: terminology resolution, evidence inspection, graph relationships, capability mapping, pathways and accountable next actions in one continuous experience.

Synthetic public demonstration only. No real patient records, clinical decisions, provider availability or eligibility determinations are represented here.
Universal front door
Start with one healthcare concept
Demo online
One platform · different missions

Switch the stakeholder.
Watch the workflow change.

The intelligence foundation stays connected, but patients, clinicians, hospitals, life sciences, researchers and public-sector teams need different views and actions.

Trust Receipt™

A result should carry
its evidence with it.

Instead of one opaque “AI confidence” number, Disease Intelligence separates identity, evidence, provenance, freshness, verification and uncertainty so people can inspect why a result appears.

Illustrative result receipt

PCOS → reproductive endocrinology capability

Identity certainty
96
Evidence quality
88
Provenance
94
Freshness
82
Verification
76
Illustrative synthetic scores demonstrate the information architecture, not measured clinical performance.
Explainability trail
Concept canonicalisedPCOS synonyms resolved to one canonical disease concept.
Evidence context attachedSource class, provenance, conflicts and freshness remain inspectable.
Capability relationship traversedThe graph connects disease requirements to capability types.
Human boundary retainedNo diagnosis, prescribing or clinical eligibility is inferred from the demo.
DI Signal™

Intelligence is also about
what changed.

Network Pulse demonstrates the type of change monitoring that can make Disease Intelligence useful between searches: evidence shifts, trial updates, capability verification, availability and workflow signals.

14
Meaningful changes

Illustrative changes across saved conditions, evidence, organisations and pathways.

3
Review required

Signals where provenance, freshness or conflict state should be inspected.

6
Network opportunities

Potential capability, research or collaboration connections surfaced by the graph.